Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 25.70
+2.30 (9.83%)
Sep 5, 2025, 1:23 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Factory Operations | 1.16B | Log In | Log In | Log In | Log In | Upgrade |
Factory Operations Growth | 37.28% | Log In | Log In | Log In | Log In | Upgrade |
Global Business | 59.92M | Log In | Log In | Log In | Log In | Upgrade |
Global Business Growth | 53.57% | Log In | Log In | Log In | Log In | Upgrade |
Medical Affairs | - | Log In | Log In | Log In | Log In | Upgrade |
Medical Affairs Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Taiwan | 826.45M | Log In | Log In | Log In | Log In | Upgrade |
Taiwan Growth | 21.57% | Log In | Log In | Log In | Log In | Upgrade |
United States | 325.38M | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 82.30% | Log In | Log In | Log In | Log In | Upgrade |
China | 34.43M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 191155.56% | Log In | Log In | Log In | Log In | Upgrade |
Philippines | 13.25M | Log In | Log In | Log In | Log In | Upgrade |
Philippines Growth | -44.34% | Log In | Log In | Log In | Log In | Upgrade |
Other | 23.31M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 199.00% | Log In | Log In | Log In | Log In | Upgrade |
Ireland | - | Log In | Log In | Log In | Log In | Upgrade |
Ireland Growth | - | Log In | Log In | Log In | Log In | Upgrade |
China and Others | - | Log In | Log In | Log In | Log In | Upgrade |
China and Others Growth | - | Log In | Log In | Log In | Log In | Upgrade |